| Home use of an artificial beta cell in type 1 diabetes H Thabit, M Tauschmann, JM Allen, L Leelarathna, S Hartnell, ... New England Journal of Medicine 373 (22), 2129-2140, 2015 | 509 | 2015 |
| Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open … L Bally, H Thabit, H Kojzar, JK Mader, J Qerimi-Hyseni, S Hartnell, ... The Lancet Diabetes & Endocrinology 5 (4), 261-270, 2017 | 154 | 2017 |
| Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study L Leelarathna, S Dellweg, JK Mader, JM Allen, C Benesch, W Doll, ... Diabetes Care 37 (7), 1931-1937, 2014 | 154 | 2014 |
| Closing the loop in adults, children and adolescents with suboptimally controlled type 1 diabetes under free living conditions: a psychosocial substudy KD Barnard, T Wysocki, V Ully, JK Mader, TR Pieber, H Thabit, ... Journal of diabetes science and technology 11 (6), 1080-1088, 2017 | 118 | 2017 |
| Reduced burden of diabetes and improved quality of life: experiences from unrestricted day‐and‐night hybrid closed‐loop use in very young children with type 1 diabetes G Musolino, K Dovc, CK Boughton, M Tauschmann, JM Allen, K Nagl, ... Pediatric diabetes 20 (6), 794-799, 2019 | 95 | 2019 |
| Home use of day-and-night hybrid closed-loop insulin delivery in very young children: a multicenter, 3-week, randomized trial M Tauschmann, JM Allen, K Nagl, M Fritsch, J Yong, E Metcalfe, ... Diabetes Care 42 (4), 594-600, 2019 | 92 | 2019 |
| Variability of insulin requirements over 12 weeks of closed-loop insulin delivery in adults with type 1 diabetes Y Ruan, H Thabit, L Leelarathna, S Hartnell, ME Willinska, S Dellweg, ... Diabetes Care 39 (5), 830-832, 2016 | 59 | 2016 |
| Humoral immune response to COVID‐19 vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: the prospective COVAC‐DM cohort study C Sourij, NJ Tripolt, F Aziz, F Aberer, P Forstner, AM Obermayer, H Kojzar, ... Diabetes, Obesity and Metabolism 24 (5), 849-858, 2022 | 57 | 2022 |
| Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized … O Moser, ML Eckstein, A Mueller, P Birnbaumer, F Aberer, G Koehler, ... Diabetic Medicine 36 (5), 606-611, 2019 | 38 | 2019 |
| Efficacy and safety of intermittent fasting in people with insulin-treated type 2 diabetes (INTERFAST-2)—A randomized controlled trial A Obermayer, NJ Tripolt, PN Pferschy, H Kojzar, F Aziz, A Müller, ... Diabetes care 46 (2), 463-468, 2023 | 33 | 2023 |
| Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial O Moser, ML Eckstein, A Mueller, P Birnbaumer, F Aberer, G Koehler, ... Diabetes, Obesity and Metabolism 21 (2), 349-356, 2019 | 31 | 2019 |
| Pre-exercise blood glucose levels determine the amount of orally administered carbohydrates during physical exercise in individuals with type 1 diabetes—a randomized cross … O Moser, ML Eckstein, A Mueller, P Birnbaumer, F Aberer, G Koehler, ... Nutrients 11 (6), 1287, 2019 | 30 | 2019 |
| Impact of COVID-19 vaccination on glycemia in individuals with type 1 and type 2 diabetes: substudy of the COVAC-DM study F Aberer, O Moser, F Aziz, C Sourij, H Ziko, J Lenz, F Abbas, ... Diabetes Care 45 (2), e24-e26, 2022 | 26 | 2022 |
| The distinct prandial and basal pharmacodynamics of IDegAsp observed in younger adults are preserved in elderly subjects with type 1 diabetes M Brunner, T Pieber, S Korsatko, H Kojzar, AL Svendsen, H Haahr Drugs & Aging 32, 583-590, 2015 | 24 | 2015 |
| Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes Y Ruan, L Bally, H Thabit, L Leelarathna, S Hartnell, M Tauschmann, ... Diabetes, Obesity and Metabolism 20 (8), 2004-2008, 2018 | 23 | 2018 |
| A head‐to‐head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot O Moser, M Pandis, F Aberer, H Kojzar, D Hochfellner, H Elsayed, ... Diabetes, Obesity and Metabolism 21 (4), 1043-1048, 2019 | 21 | 2019 |
| Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study … L Leelarathna, S Dellweg, JK Mader, K Barnard, C Benesch, M Ellmerer, ... BMJ open 4 (9), e006075, 2014 | 17 | 2014 |
| Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise … F Aberer, PN Pferschy, NJ Tripolt, C Sourij, AM Obermayer, F Prüller, ... Diabetes, Obesity and Metabolism 22 (2), 212-221, 2020 | 16 | 2020 |
| Behavioral patterns and associations with glucose control during 12-week randomized free-living clinical trial of day and night hybrid closed-loop insulin delivery in adults … A Emami, ME Willinska, H Thabit, L Leelarathna, S Hartnell, S Dellweg, ... Diabetes technology & therapeutics 19 (7), 433-437, 2017 | 14 | 2017 |
| Insulin bolus administration in insulin pump therapy: effect of bolus delivery speed on insulin absorption from subcutaneous tissue W Regittnig, M Urschitz, B Lehki, M Wolf, H Kojzar, JK Mader, M Ellmerer, ... Diabetes Technology & Therapeutics 21 (1), 44-50, 2019 | 11 | 2019 |
